Milestone Scientific, Inc.

170 articles with Milestone Scientific, Inc.

• Milestone Scientific to Participate in the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd

  5/27/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug instruments that provide painless and precise injections, has been invited to present at the "Summer Solstice – Best Ideas from the Buy-Side" conference, which is being held virtually on June 1 st  – 4 th , 2021. Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, is scheduled to present on Wednesday, June 2 nd , 2021 at 2:00 PM

• Milestone Scientific Reports a 61% Increase in Revenue for Q1 2021

  5/17/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March 31, 2021.

• Milestone Scientific Announces Promotion of Arjan Haverhals to CEO

  5/13/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that in connection with the Company’s previously disclosed succession plan: Leonard Osser announced his intention to resign as Interim Chief Executive Officer

• Milestone Scientific Schedules First Quarter 2021 Business Update Conference Call

  5/12/2021

  Milestone Scientific Inc. (NYSE American: MLSS) , a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, May 17, 2021 to discuss the Company’s financial results for the first quarter ended March 31, 2021, as well as the Company’s corporate progress and other developments.

• Milestone Scientific Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year

  5/3/2021

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced preliminary financial results for the first quarter of 2021.

• Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020Milestone Scientific Reports Continued Progress on Commercial Rollout of CompuFlo Epidural System

  4/1/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the full year ending December 31, 2020.

• Milestone Scientific to Present at the Q1 Virtual Investor Summit

  3/12/2021

  Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that Arjan Haverhals, CEO of Wand Dental and President of Milestone Scientific, will be presenting at the Q1 Virtual Investor Summit on March 24 th .

• Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South Carolina

  3/2/2021

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has begun selling CompuFlo® / CathCheck™ disposables to the Medical University of South Carolina (MUSC).

• Milestone Scientific Inc. Announces Breakthrough CompuPulse System and Receives Notice of Allowance for U.S. PatentCompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and catheter placement

  2/24/2021

  Milestone Scientific Inc. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to its new CompuPulse System, which integrates the Company’s CompuWave™ technology with a manual syringe.

• Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural Instruments and Disposables to University Hospital of Würzburg in Germany

  2/23/2021

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has begun selling its CompuFlo® Epidural Instrument and related disposables to the University Hospital of Würzburg , one of the leading national hospitals in Germany. Dr. Peter Kranke, Professor of Anesthesia in the Department of Anesthesia

• Milestone Scientific Adds Three Additional Premier Distributors Providing Robust U.S. Coverage and a New Distributor in Canada

  2/16/2021

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has signed three additional distribution agreements in the U.S. with Goetze Dental, Midwest Dental Equipment & Supply, and Scott’s Dental, to sell its Wand® Single Tooth Anesthesia (STA) System.

• Milestone Scientific to Participate in the Winter Wonderland Conference- Best Ideas from the Buy-Side

  2/12/2021

  Milestone Scientific Inc., a leading developer of computerized drug instruments that provide painless and precise injections, announced that it will be presenting at the Winter Wonderland Conference, hosted by The MicroCap Rodeo, being held virtually on February 16th - February 19th, 2021.

• Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independent Distributors Covering Atlanta and Tennessee

  2/9/2021

  Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has signed two additional distribution agreements with Atlanta Dental and Nashville Dental for its Wand® Single Tooth Anesthesia (STA) System. Atlanta Dental and Nashville Dental

• Milestone Scientific Inc. Announces It has Begun Implementing Three-Year Strategy to Expand the World-Wide Global Dental Market

  1/19/2021

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, announced that it has signed agreements with US Dental Depot and IQ Dental Supply for its Wand® Single Tooth Anesthesia System.

• Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural and CathCheck Disposables to Regional Medical Center (RMC), a Premier Regional Healthcare System

  1/12/2021

  Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has begun selling CompuFlo® Epidural and CathCheck disposables to Regional Medical Center (RMC) , a premier regional healthcare system in South Carolina. Arjan Haverhals, President of Milestone Scientific, stated, “I would like to thank the entire anes

• Milestone Scientific Inc. CEO Increases Stock Ownership through Option Exercise

  1/11/2021

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, reported that the Company’s Interim CEO, Leonard Osser, completed the sale of shares to cover the cost of his options and associated taxes, as previously announced on December 16, 2020.

• Milestone Scientific Inc. Announces Agreement with Bitmedical AG to Distribute the CompuFlo® Epidural Instrument Across Austria and Switzerland

  1/11/2021

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has entered into an agreement with Bitmedical AG (“Bitmedical”) to distribute the CompuFlo® Epidural Instrument and CathCheck™ System, as well as related disposables in Switzerland and Austria.

• Milestone Scientific Inc. Raises Revenue Guidance to Over $2 Million for Q4 2020

  1/6/2021

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today raised revenue guidance to over $2 million for the fourth quarter of 2020, a 67% sequential increase over $1.2 million reported for the third quarter of 2020. Arjan Haverhals, President of Milestone Scientific and CEO of Wand Dental Inc., stated, “I am pleased to report

• Milestone Scientific, Inc. Unveils Study Findings: Where Is Anesthesiology Headed?

  1/5/2021

  Perception Study Results Reveal Perceptions and Attitudes of the Medical Profession; Anesthesiologists Seek Innovation and Change

• Milestone Scientific Inc. Announces Entrée into the Nationally Recognized University of Texas Medical Branch at Galveston with its CompuFlo Disposables

  1/4/2021

  Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that as per a purchase order the Company received in late 2020, it has begun selling CompuFlo® disposables to the University of Texas Medical Branch at Galveston (UTMB), an institution of the University of Texas System and agency of the State of Texas. UTMB is a